✦ LIBER ✦

Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: Results from a randomized clinical trial

✍ Scribed by Robin Pokrzywinski; Angeles Alvarez Secord; Laura J. Havrilesky; Larry E. Puls; Robert W. Holloway; George S. Lewandowski; Robert V. Higgins; Lawrence R. Nycum; Matthew F. Kohler; Dennis A. Revicki

Book ID: 113963418
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 384 KB
Volume: 123
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.08.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, phase 2 clini

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer

✍ Angeles Alvarez Secord; Andrew Berchuck; Robert V. Higgins; Lawrence R. Nycum; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

8029 POSTER Health-Related Quality of Li

8029 POSTER Health-Related Quality of Life (HRQoL)/Patient Reported Outcomes (PRO) of Patients (pts) With Partially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Treated in a Randomized Phase III Trial of Trabectedin and Pegylated Liposomal Doxorubicin (PLD) Vs PLD Alone (OVA-301) – an Exploratory Analysis

✍ Verqote, I.; Bidzinski, M.; Kelley, J.; Vasanthan, S.; Runnebaum, I.; Vermorken, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB